277
Views
0
CrossRef citations to date
0
Altmetric
Pain Medicine

Identification of prescription opioid misuse and abuse behaviors and risk factors in chronic pain patients using the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ)

, , , , , , , , & show all
Pages 441-450 | Received 27 Sep 2022, Accepted 26 Jan 2023, Published online: 10 Feb 2023

References

  • Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and High-Impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006.
  • Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
  • Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet. 2011;377(9784):2226–2235.
  • Centers for Disease Control and Prevention. 2018. Annual surveillance report of drug-related risks and outcomes; 2018 [cited 2019 Jun 20]. Available from: https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf
  • Gomes T, Tadrous M, Mamdani MM, et al. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2):e180217.
  • Centers for Disease Control and Prevention. CDC guideline for prescribing opioids for chronic pain — United States, 2016; 2016 [cited 2019 Jun 20]. Available from: https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F65%2Frr%2Frr6501e1er.htm
  • Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296.
  • Coyne KS, Barsdorf AI, Brooks A, et al. Establishing the content validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) among chronic pain patients. Curr Med Res Opin. 2021;37(3):505–514.
  • Coyne KS, Barsdorf AI, Currie BM, et al. Construct validity and reproducibility of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ). Curr Med Res Opin. 2021;37(3):493–503.
  • Coyne KS, Schnoll S, Butler SF, et al. Clinical scoring algorithm for the prescription opioid misuse and abuse questionnaire (POMAQ). Curr Med Res Opin. 2022; 38(6):971-980.
  • Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. Vol. 718. Hoboken (NJ): John Wiley & Sons; 2010.
  • Cochran G, Hruschak V, Bacci JL, et al. Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: a latent class analysis. Res Social Adm Pharm. 2017;13(6):1055–1061.
  • Green TC, Black R, Grimes Serrano JM, et al. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS One. 2011;6(11):e27244.
  • Agrawal A, Lynskey MT, Madden PA, et al. A latent class analysis of illicit drug abuse/dependence: results from the national epidemiological survey on alcohol and related conditions. Addiction. 2007;102(1):94–104.
  • Clark SL, Gillespie NA, Adkins DE, et al. Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse. Addict Behav. 2016;53:132–140.
  • Assanangkornchai S, Li J, McNeil E, et al. Clusters of alcohol and drug use and other health-risk behaviors among Thai secondary school students: a latent class analysis. BMC public Health. 2018;18(1):1272.
  • Evans-Polce R, Lanza S, Maggs J. Heterogeneity of alcohol, tobacco, and other substance use behaviors in US college students: a latent class analysis. Addict Behav. 2016;53:80–85.
  • Coyne KS, Barsdorf AI, Currie BM, et al. Insight into chronic pain in the United States: descriptive results from the prescription opioid misuse and abuse questionnaire (POMAQ) validation study. Curr Med Res Opin. 2021;37(3):483–492.
  • Dorrance KA, Ramchandani S, Neil N, et al. Leveraging the military health system as a laboratory for health care reform. Mil Med. 2013;178(2):142–145.
  • PROC LCA & PROC LTA (Version 1.3.2) [Software]. University Park: The Methodology Center, Penn State; 2015. Available from: http://methodology.psu.edu
  • Lanza ST, Dziak JJ, Huang L, et al. PROC LCA & PROC LTA users’ guide (Version 1.3.2). University Park: The Methodology Center, Penn State; 2015. Available from: http://methodology.psu.edu
  • Lanza ST, Bray BC, Collins LM. An introduction to latent class and latent transition analysis. In: Schinka JA, Velicer WF, Weiner IB, editors. Handbook of psychology. 2nd ed., Vol. 2. Hoboken (NJ): Wiley; 2013. p. 691–716.
  • Lanza ST, Collins LM, Lemmon DR, et al. PROC LCA: a SAS procedure for latent class analysis. Struct Equ Modeling. 2007;14(4):671–694.
  • Lanza ST, Tan X, Bray BC. Latent class analysis with distal outcomes: a flexible model-based approach. Struct Equ Modeling. 2013;20(1):1–26.
  • Laska MN, Pasch KE, Lust K, et al. Latent class analysis of lifestyle characteristics and health risk behaviors among college youth. Prev Sci. 2009;10(4):376–386.
  • Manchikanti L, Damron KS, Pampati V, et al. Prospective evaluation of patients with increasing opiate needs: prescription opiate abuse and illicit drug use. Pain Phys. 2004;7(3):339–344.
  • National Academies of Sciences, Engineering, and Medicine. Trends in opioid use, harms, and treatment. In: Phillips JK, Ford MA, Bonnie RJ, editors. Committee on pain management and regulatory strategies to address prescription opioid abuse. Washington (DC): National Academies Press; 2017. p. 187–265.
  • Quality SCfBHSa. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health: US Department of Health and Human Services SAMHSA; 2019 [cited 2019]. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
  • Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health (HHS publication no. SMA 18-5068, NSDUH series H-53. Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018 [cited 2019 Mar 13]. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf
  • Hudgins JD, Porter JJ, Monuteaux MC, et al. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16(11):e1002922.
  • Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–362.
  • Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7(4):281–289.
  • Wijnhoven HA, de Vet HC, Picavet HS. Prevalence of musculoskeletal disorders is systematically higher in women than in men. Clin J Pain. 2006;22(8):717–724.
  • Kim HS, Rhee PL, Park J, et al. Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21(2):468–473.
  • Arout CA, Sofuoglu M, Bastian LA, et al. Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans health administration study. J Womens Health. 2018;27(8):1035–1044.
  • Hasin DS, Shmulewitz D, Stohl M, et al. Diagnosing prescription opioid use disorder in patients using prescribed opioids for chronic pain. Am J Psychiatry. 2022;179(10):715–725.
  • Phillips DL, Clancy KJ. Some effects of “social desirability” in survey studies. Am J Sociol. 1972;77(5):921–940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.